Benchmark has revised its price target for Enovix (ENVX, Financial), reducing it from $25 to $15, while maintaining a Buy rating for the stock. This adjustment comes as the company progresses from product sampling to anticipated market launches slated for 2026.
The analyst notes that the pace of Enovix's product introduction is closely tied to the volume of customer orders, which are expected to commence on a smaller scale before significant growth. This strategic shift has led to a revised revenue forecast for 2026, now estimated at $106.4 million, down from the previous projection of $144.5 million.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 12 analysts, the average target price for Enovix Corp (ENVX, Financial) is $27.08 with a high estimate of $100.00 and a low estimate of $10.00. The average target implies an upside of 350.64% from the current price of $6.01. More detailed estimate data can be found on the Enovix Corp (ENVX) Forecast page.
Based on the consensus recommendation from 12 brokerage firms, Enovix Corp's (ENVX, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Enovix Corp (ENVX, Financial) in one year is $36.53, suggesting a upside of 507.82% from the current price of $6.01. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Enovix Corp (ENVX) Summary page.
